» Articles » PMID: 24105662

Common Community-acquired Infections and Subsequent Risk of Multiple Myeloma: a Population-based Study

Overview
Journal Int J Cancer
Specialty Oncology
Date 2013 Oct 10
PMID 24105662
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The role of bacteria and viruses as aetiological agents in the pathogenesis of cancer has been well established for several sites, including a number of haematological malignancies. Less clear is the impact of such exposures on the subsequent development of multiple myeloma (MM). Using the population-based U.S. Surveillance Epidemiology and End Results-Medicare dataset, 15,318 elderly MM and 200,000 controls were identified to investigate the impact of 14 common community-acquired infections and risk of MM. Odds ratios (ORs) and associated 95% confidence intervals (CIs) were adjusted for sex, age and calendar year of selection. The 13-month period prior to diagnosis/selection was excluded. Risk of MM was increased by 5-39% following Medicare claims for eight of the investigated infections. Positive associations were observed for several infections including bronchitis (adjusted OR 1.14, 95% CI 1.09-1.18), sinusitis (OR 1.15, 95% CI 1.10-1.20) pneumonia (OR 1.27, 95% CI 1.21-1.33), herpes zoster (OR 1.39, 95% CI 1.29-1.49) and cystitis (OR 1.09, 95% CI 1.05-1.14). Each of these infections remained significantly elevated following the exclusion of more than 6 years of claims data. Exposure to infectious antigens may therefore play a role in the development of MM. Alternatively, the observed associations may be a manifestation of an underlying immune disturbance present several years prior to MM diagnosis and thereby part of the natural history of disease progression.

Citing Articles

Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy.

Rodriguez-Garcia A, Ancos-Pintado R, Garcia-Vicente R, Ortiz-Ruiz A, Arroyo A, Navarro M Microbiome. 2025; 13(1):56.

PMID: 40022244 PMC: 11869585. DOI: 10.1186/s40168-025-02045-6.


Determination of the target of monoclonal immunoglobulins: a novel diagnostic tool for individualized MGUS therapy, and prevention and therapy of smoldering and multiple myeloma.

Hermouet S, Bigot-Corbel E, Harb J Front Immunol. 2023; 14:1253363.

PMID: 38022528 PMC: 10644846. DOI: 10.3389/fimmu.2023.1253363.


Exploring the role of viral hepatitis in plasma cell disorders.

ODonnell E Haematologica. 2023; 109(1):19-20.

PMID: 37470153 PMC: 10772513. DOI: 10.3324/haematol.2023.283461.


Impact of viral hepatitis therapy in multiple myeloma and other monoclonal gammopathies linked to hepatitis B or C viruses.

Rodriguez-Garcia A, Mennesson N, Hernandez-Ibarburu G, Morales M, Garderet L, Bouchereau L Haematologica. 2023; 109(1):272-282.

PMID: 37199121 PMC: 10772493. DOI: 10.3324/haematol.2023.283096.


Editorial: The Role of Microorganisms in Multiple Myeloma.

Linares M, Hermouet S Front Immunol. 2022; 13:960829.

PMID: 35844583 PMC: 9281403. DOI: 10.3389/fimmu.2022.960829.


References
1.
Weiss B, Abadie J, Verma P, Howard R, Kuehl W . A monoclonal gammopathy precedes multiple myeloma in most patients. Blood. 2009; 113(22):5418-22. PMC: 2689043. DOI: 10.1182/blood-2008-12-195008. View

2.
Kalambokis G, Christou L, Tsianos E . Multiple myeloma presenting with an acute bacterial infection. Int J Lab Hematol. 2009; 31(4):375-83. DOI: 10.1111/j.1751-553X.2009.01154.x. View

3.
Augustson B, Begum G, Dunn J, Barth N, Davies F, Morgan G . Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2005; 23(36):9219-26. DOI: 10.1200/JCO.2005.03.2086. View

4.
Mantovani A, Allavena P, Sica A, Balkwill F . Cancer-related inflammation. Nature. 2008; 454(7203):436-44. DOI: 10.1038/nature07205. View

5.
Engels E, Pfeiffer R, Ricker W, Wheeler W, Parsons R, Warren J . Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol. 2011; 174(7):860-70. PMC: 3203375. DOI: 10.1093/aje/kwr146. View